474 related articles for article (PubMed ID: 28480719)
21. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.
Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J
BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742
[TBL] [Abstract][Full Text] [Related]
22. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
23. [Stereotactic Body Radiotherapy for Early Stage NSCLC - What Is the Evidence?].
Guckenberger M
Zentralbl Chir; 2017 Sep; 142(S 01):S17-S25. PubMed ID: 28958106
[TBL] [Abstract][Full Text] [Related]
24. Novel Dose Escalation Approaches for Stereotactic Body Radiotherapy to Adrenal Oligometastases: A Single-Institution Experience.
Figura NB; Oliver DE; Mohammadi H; Martinez K; Grass GD; Hoffe SE; Johnstone PAS; Frakes JM
Am J Clin Oncol; 2020 Feb; 43(2):107-114. PubMed ID: 31764023
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Klement RJ; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2021 Jul; 149(2):358-370. PubMed ID: 33682927
[TBL] [Abstract][Full Text] [Related]
26. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
28. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
29. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
Spratt DE; Wu AJ; Adeseye V; Din SU; Shaikh F; Woo KM; Zhang Z; Foster A; Rosenzweig KE; Gewanter R; Huang J; Rimner A
Clin Lung Cancer; 2016 May; 17(3):177-183.e2. PubMed ID: 26602271
[TBL] [Abstract][Full Text] [Related]
30. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
[TBL] [Abstract][Full Text] [Related]
31. Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice.
Rusthoven CG; Yeh N; Gaspar LE
Cancer J; 2015; 21(5):404-12. PubMed ID: 26389766
[TBL] [Abstract][Full Text] [Related]
32. Hypofractionated radiation therapy as palliative management for symptomatic and local control of advanced thoracic malignancies.
Ahn GS; Bruggeman AR; Qiao EM; Moiseenko V; Ray X; Sharabi A; Murphy JD; Sandhu AP
Ann Palliat Med; 2021 Oct; 10(10):10360-10368. PubMed ID: 34670382
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC).
Janssen S; Käsmann L; Rudat V; Rades D
Anticancer Res; 2016 Feb; 36(2):825-8. PubMed ID: 26851047
[TBL] [Abstract][Full Text] [Related]
34. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
Guerrero E; Ahmed M
Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
[TBL] [Abstract][Full Text] [Related]
35. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
Riesterer O
Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies.
Franzese C; Francolini G; Nicosia L; Alongi F; Livi L; Scorsetti M
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):50-56. PubMed ID: 32723486
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
Cancer; 2015 Dec; 121(23):4222-30. PubMed ID: 26348268
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.
Holy R; Piroth M; Pinkawa M; Eble MJ
Strahlenther Onkol; 2011 Apr; 187(4):245-51. PubMed ID: 21424513
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
40. What do radiation oncologists require for future advancements in lung SBRT?
Ricardi U; Badellino S; Filippi AR
Phys Med; 2017 Dec; 44():150-156. PubMed ID: 27914779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
